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Summary In a population-based, matched case-control study from southern Sweden of 400 patients with a
first diagnosis of malignant melanoma and 640 healthy control subjects aged 15-75 years, the association
between commonly prescribed drugs, alcohol, smoking and malignant melanoma was evaluated. In addition,
the relation between reproductive and hormonal factors and melanoma in women was studied. It was found
that certain specific types of prescribed drugs, i.e. beta-blockers, hydralazines and benzodiazepines, may
increase the risk of melanoma development. However, these associations were diminished, at least for
benzodiazepines, after controlling for host factors. As these findings are unconfirmed, and may be due to
chance or confounding, further studies are warranted. The risk of malignant melanoma was not influenced by
alcohol consumption or smoking habits. Our results do not suggest an association between oral contraceptives
and melanoma. Furthermore, reproductive factors were not independent risk factors for melanoma. However,
increasing number of live births seemed to be protective (P for trend = 0.01). There is a need for further
research to be able to draw firm conclusions on the relation between number of live births and melanoma. The
results based on histopathological re-examinations and those based on tumour registry data were essentially the
same.
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Most studies of risk factors for developing malignant
melanoma have focused on sun exposure and constitutional
factors. The evidence relating cutaneous melanoma to
sunlight is now very strong, however, the association seems
to be complex (Elwood, 1992). It is therefore possible that
other factors could act as co-carcinogenes with sunlight. In
addition, other factors may by themselves initiate or promote
melanoma development.
It is known that a variety of chemical substances including
medicaments of quite different categories (e.g. antibiotics,
psychotropic drugs, etc.) have affinity for melanin (Larsson,
1993) and that many commonly used drugs may increase the
sensitivity of our skin to sunlight (Allen, 1993). However, to
date there exists in the epidemiological literature no study of
melanoma risk associated with use of prescribed drugs.
The role of alcohol intake has been investigated in several
epidemiological studies, but the results so far are inconsistent.
In four studies an association between alcohol intake and
increased risk of melanoma has been reported (Williams and
Horm, 1977; Holman et al., 1986; Stryker et al., 1990; Bain et
al., 1993), while in an additional study an inverse relation has
been demonstrated (0sterlind et al., 1988a). In three other
studies no consistent association between alcohol consump-
tion and melanoma risk has been shown (Green et al., 1986;
Adami et al., 1992; Kirkpatrick et al., 1994). Furthermore,
tobacco smoking has been evaluated as a risk factor, but it
has not been found to influence melanoma risk significantly
(Williams and Horm, 1977; Paffenberger et al., 1978; Green
et al., 1986; Holman et al., 1986; 0sterlind et al., 1988a).
There has also been a continued interest in the association
between sexual hormones (exogenous and/or endogenous) in
females and malignant melanoma, but the results have been
predominantly negative (Beral et al., 1977; Adam et al., 1981;
Bain et al., 1982; Helmrich et al., 1984; Holman et al., 1984;
Green and Bain, 1985; Osterlind et al., 1988b; Hannaford et
al., 1991; Palmer et al., 1992). However, there have been
some significantly elevated odds ratios for long duration of
oral contraceptive use (Holly et al., 1983; Beral et al., 1984;
Le et al., 1992) and for assorted menstrual and reproductive
factors (Holly et al., 1983; Gallagher et al., 1985; Zanetti et
al., 1990; Le et al., 1992). It is noteworthy that each of the
individual menstrual and reproductive variables have been
considered only in relatively few studies.
We have conducted a population-based, matched case-
control study of malignant melanoma in the South Swedish
Health Care Region. The influence of sunlight, use of
sunbeds or sunlamps, sunscreen use and constitutional
factors on melanoma risk have been previously reported
(Westerdahl et al., 1994a,b, 1995). We report here on the risk
of developing malignant melanoma in relation to use of
prescribed drugs, alcohol intake, smoking habits, and
reproductive and hormonal factors.
Materials and methods
Detailed descriptions of identification of cases and controls,
as well as data collection have been reported in previous
reports (Westerdahl et al., 1994a,b).
In brief, the study identified 509 persons (females, 53.4%),
aged 15-75 years, in the South Swedish Health Care Region
with a first histopathological diagnosis of malignant
melanoma between July 1 1988 and June 30 1990, according
to the population-based Regional Tumour Registry. The
permission of the physician responsible for the treatment of
each patient was sought. In 22 cases the physician did not
respond (owing to refusal), and in an additional 33 cases the
patient was considered ineligible by the treating physician (21
were ineligible for psychological reasons, four had not been
fully informed about their diagnosis, four had metastases,
two were dead, one had moved and one did not want to
participate). Thus, the case group comprised 454 eligible
persons.
For each of these cases two healthy controls, matched by
sex, age (within a year), and parish were selected by random
sampling from the National Population Registry of residents
of the South Swedish Health Care Region.
All eligible cases (n=454) were mailed a comprehensive
questionnaire including questions on constitutional factors,
family history, educational level, medical history, prescribed
drugs, ultraviolet radiation exposure, smoking habits, alcohol
use and endogenous and exogenous hormonal factors within
2 months following diagnosis. All selected controls (n=913)
were mailed an identical questionnaire during the same time
period. Particular attention was paid to defining variables in
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November 1995such a way that one could expect high recall with a minimum
of memory bias. Furthermore, this self-administered ques-
tionnaire has been found to provide information with good
test-retest reliability (Westerdahl et al., 1996).
A total of 403 cases (89%) and 707 controls (77%)
answered the questionnaire. Three cases with no matched
control and 67 controls with no matched case were excluded.
Thus, the subjects actually studied consisted of 400 cases
(88.1% of 454 eligible patients) and 640 healthy controls
(70.1% of 913 healthy controls selected). For almost all
variables less than 5% were missing values. No attempt was
made to complement missing values except for non-
responders who were contacted twice.
For cases and controls questions regarding use of
medicaments included: 'Have you ever, prior to diagnosis/
interview, used prescribed drugs for more than a month
continously? If yes, please give the name(s) of the drug(s)?'
The specific preparations were categorised into five groups:
antihypertensive drugs, drugs used for various heart diseases
(e.g. antiarrhythmics, cardiac glycosides and nitrates),
antimicrobial drugs, tranquillisers (sedative-hypnotics, anti-
psychotics and antidepressants), endocrine drugs, and other
drugs. In addition, the specific preparations were also
grouped according to their mechanism of action (e.g. beta-
blockers, thiazides, etc.).
Furthermore, the questionnaire yielded information on the
frequency and consumption of alcoholic beverages. Separate
assessments were made for light beer (less than 1.8 weight %
alcohol), beer, wine and distilled liquor. An estimate of total
pure-alcohol intake in grams per day was calculated for each
subject by multiplying the alcohol content of each type of
beverage by the consumption level and summing over
beverage types. Smoking habits were also elucidated.
For females the following information was collected with
regard to endogenous and exogenous hormonal exposure:
menstrual history; obstetric history; history of oral contra-
ceptive use; and history of menopausal replacement therapy.
All obtainable histopathological sections (n= 393) were
reviewed by two pathologists (AM and NJ) (Westerdahl et
al., 1995). A diagnosis of primary melanoma was rejected in
eight of the cases. Three patients were found to have
melanoma presenting in the mucosal membranes, 12 had
ocular melanoma and 29 were found to have a diagnosis of in
situ melanoma.
Analyses were performed on histopathologically confirmed
primary cutaneous malignant melanoma with the inclusion of
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six patients presenting with metastatic melanoma and seven
patients whose original diagnosis could not be re-examined
(348 cases and 562 controls)-re-examined material. In
addition, analyses were also carried out on all cases with a
first diagnosis of malignant melanoma, (according to the
Tumour Registry), who had answered the questionnaire and
also had at least one matched control (400 cases and 640
controls)-original material. Odds ratios (ORs) were com-
puted, based on matched pairs, using both univariate and
multivariate methods. In the multivariate analyses condi-
tional logistic regression was used. The multivariate models
included adjustments for hair colour (red, blond/fair, other),
number of raised naevi (none, 1-3, >3) and number of
sunburns (none, 1 -2, >3), which were important risk factors
identified in this case-control study (Westerdahl et al.,
1994a, 1995). A P-value of less than 0.05 were considered
significant and 95% confidence intervals (CIs) were used. The
statistical program Stata was used (Computing Resource
Center, Santa Monica, CA, USA). Occasional missing values
for some variables caused slight variation in the numbers of
cases and controls used for each analysis. This study had a
power of 86% in finding an odds ratio of 1.7, given that 10%
of controls were exposed, two controls per case, 400 cases
and a P-value of 0.05.
This study was approved by the Ethical Committee of the
Medical Faculty of Lund University. Informed consent was
sought from the treating physician, the patient and the
healthy control.
Results
Re-examined material
In an analysis of different categories of drugs (antihyperten-
sive drugs, drugs used for various heart diseases, antimicro-
bial drugs, tranquillisers, endocrine drugs and other drugs),
only use of antihypertensive agents showed an elevated OR
for melanoma development (OR = 1.3, 95% CI 1.0- 1.9 for
use of at least 1 month vs no use). When females and males
were considered separately, use of antihypertensive drugs and
tranquillisers respectively, were associated with melanoma in
males (OR = 1.6, 95% CI 1.0-2.8 and OR = 2.2, 95% CI
1.0-5.7 respectively) whereas among females no elevated
ORs were found. Adjusting for history of sunburns, hair
colour and number of raised naevi had a negligible effect on
the risk estimates for antihypertensive drug use (adjusted OR
Table I Odds ratios for developing malignant melanoma in relation to commonly used antihypertensive drugs and transquilisers in a matched
case-control study of malignant melanoma in the South Swedish Health Care Region between 1988 and 1990
Factor and category No. of cases No. of controls Odss ratio crude (95% CI) Odds ratio adjusteda (95% CI)
Beta-blockers
No 301 512 1.0b 1.0b
Yes 47 48 1.7 (1.1-2.7) 1.7 (1.0-2.7)c
Thiazides
No 328 535 1.0b ".0b
Yes 20 25 1.4 (0.7-2.7) 1.4 (0.7-2.8)
Other diuretics
No 344 547 1.0b 1.0b
Yes 4 13 0.4 (0.1-1.5) 0.4 (0.1-1.3)
Hydralazines
No 343 562
Yes 5 0 PO.008d
Benzodiazepines
No 336 550 1.0"
Yes 12 10 2.1 (1.0-5.1) 1.8 (0.7-4.4)e
Antidepressants (tri- or tetracyclic)
No 337 547 1.ob 1.0b
Yes 11 13 1.6 (0.7-3.5) 1.6 (0.7-3.6)
Neuroleptics
No 343 555 1.0" 1.0"
Yes 5 5 1.8 (0.5-6.1) 1.4 (0.4-5.2)
aAdjusted for history ofsunburns and host factors (haircolour, number ofraised naevi). bReference category.COR = 1.8, 95% CI 1.2-2.9, when
only adjusted forhistory ofsunbums.dlt was notpossible to calculate odds ratio and confidence interval due to no exposed controls. P-value based
on Fisher's exact test. OR= 1.8, 95% CI 1.0-4.4, when only adjusted for history ofsunburns.Drugs, alcohol, smoking, hormones and melanoma
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= 1.3, 95% CI 1.0-1.9 for both gender and adjusted OR =
1.6, 95% CI 1.0-2.9 for men). However, the elevated OR
among men for use of tranquillisers was essentially the same
after adjustments for history of sunburns, but became non-
significant after host factors (hair colour and/or raised naevi)
also were taken into account (adjusted OR = 1.8, 95% CI
0.7-4.8).
In Table I analyses restricted to specific types of
commonly used antihypertensive drugs and tranquillisers
are shown. As can be seen, use of beta-blockers was
associated with melanoma development (adjusted OR =
1.7, 95% CI 1.0-2.7 for use of at least 1 month vs no use).
The relation between use of benzodiazepines and melanoma
was, in the same manner as described above (for use of
tranquillisers), diminished in adjusted analyses. No sex-
specific analyses were performed owing to small numbers.
Use of hydralazines showed also an association with
melanoma (P <0.01), however, it was not possible to
calculate OR and CI owing to no exposed controls. There
were no significant correlations between any of the specific
types of drugs and the host factors used in the conditional
logistic regression model in Table I.
Both among cases and among controls 83% were found to
ever consume alcohol. Intake of any alcoholic beverage was
not related to melanoma development (adjusted OR = 1.0,
95% CI 0.7-1.4 for any alcohol intake vs no alcohol intake).
An elevated OR for development of melanoma was found
with frequent intake of distilled liquor (adjusted OR = 1.4,
95% CI 1.0- 1.9 for more than once a month vs less than
once a month). However, no association was found between
risk of melanoma and frequent intake of either wine, beer or
light beer (data not shown). Total alcohol intake (g day-')
was not related with melanoma risk (Table II), nor was
alcohol intake categorised as light beer, beer, wine or distilled
liquor (data not shown). Virtually the same ORs were seen
when men and women were considered separately. The same
was true for individuals younger than age 50 years and older
than age 50 years respectively.
No significant relation between tobacco smoking and
malignant melanoma was found (adjusted OR = 0.9, 95%
CI 0.7-1.2 for ever smoker vs never smoker) (Table II). A
total of 52% of the cases and 57% of the controls reported
ever smoking. Essentially the same results were seen in sex-
specific analyses.
Table n Odds ratios for developing malignant melanoma in relation to total pure-alcohol intake and smoking habits in a matched case-
control study of malignant melanoma in the South Swedish Health Care Region between 1988 and 1990
Odds ratio crude Odds ratio adjusteda
Factor and category No. of cases No. of controls (95% CI) (95% CI) Test for trend P-value
Total pure-alcohol intake (g day-')
0 84 134
1 -9 160 294 0.7 (0.5-1.0) 0.8 (0.6-1.1)
10-19 37 60 0.8 (0.5-1.3) 0.9 (0.5-1.5)
20+ 25 35 0.9 (0.5-1.6) 0.9 (0.5-1.8) >0.05
Never smoker 167 242 1 0b 1.0b
Ever smoker 181 318 0.9 (0.7-1.2) 0.9 (0.7-1.2)
Cigarettes 160 277 0.9 (0.7-1.2) 0.9 (0.7-1.2)
Pipe and cigars 21 41 0.8 (0.5-1.4) 0.9 (0.5-1.7)
Ex-smoker, cigarettes 88 127 1.0 (0.3-3.5) 1.0 (0.3-3.5)
Current smoker, cigarettes 72 150 0.7 (0.5-1.1) 0.7 (0.5-1.1)
No. of cigarettes/day
1-19 44 97 0.7 (0.5-1.1) 0.7 (0.5-1.1)
20 28 53 0.8 (0.5-1.3) 0.6 (0.3-1.1)
aAdjusted for history ofsunburns and host factors (i.e. hair colour and number ofraised naevi). bReference category
Table III Odds ratios for developing malignant melanoma in relation to parity factors and duration of oral contraceptive use in a matched
case-control study of malignant melanoma in the South Swedish Health Care Region between 1988 and 1990
Odds ratio crude Odds ratio adjusteda
Factor and category No. of cases No. of controls (95% CI) (95% CI) Testfor trend P-value
Number of pregnancies
0 35 41
1 -2 89 129 1.0 (0.6-1.7) 1.1 (0.6-2.1)
3 -4 40 86 0.7 (0.4-1.3) 0.7 (0.3-1.4)
5+ 13 22 0.8 (0.3-2.0) 1.0 (0.4-2.5) 0.4
Number of live births
0 39 45 1.0 1.0b
1-2 102 158 0.8 (0.5-1.4) 0.9 (0.5-1.6)
3+ 38 84 0.6 (0.3-1.0) 0.6 (0.3-1.1) 0.01
Age at first birth
< 25 68 117
25 -29 54 86 1.1 (0.7-1.8) 1.0 (0.6-1.6)
30+ or never 56 83 1.2 (0.7-1.9) 0.8 (0.4-1.5) 0.5
Oral contraceptive use
Never used 108 182
<4 years 26 30 1.8 (0.9-3.5) 2.2 (0.9-4.6)
4-8 years 20 28 1.3 (0.6-2.8) 1.5 (0.7-3.5)
>8 years 19 40 0.9 (0.5-1.7) 1.0 (0.5-2.0) 0.7
aFor number ofpregnancies and live births respectively, adjusted odds ratios were obtained from a model including host factors (i.e. hair colour
and raised naevi), history ofsunburn and age at first birth. For age at first birth, adjusted odds ratios were obtained from a model including host
factors (i.e. hair colour and raised naevi), history of sunburns and number of live births. For oral contraceptive use adjusted odds ratios were
obtained from a model including host factors and history ofsunburns. bReference category.Analyses on endogenous and exogenous hormonal
exposure were performed on 180 female cases and 292
female controls.
Neither age at menarche nor age at menopause were
related to risk of developing melanoma (data not shown). A
total of 45% of cases and controls respectively were pre-
menopausal. The OR for developing malignant melanoma
after ever being pregnant was 0.8 (95% CI 0.4-1.5), adjusted
for history of sunburns, hair colour and number of raised
naevi. The relation between other reproductive factors and
melanoma risk is shown in Table III. Whereas no association
was found with either age at first child or number of
pregnancies, there was a significant trend of decreasing risk
with increasing number ofchildren (P = 0.01). The estimated
ORs were unaffected by educational level. Number of
stillbirths or number of miscarriages were not recorded.
Use of oral contraceptives was not related to melanoma
development. Among cases 40% and among controls 37%
reported ever using oral contraceptives (adjusted OR = 1.6,
95% CI 0.9-2.8 for ever used oral contraceptives vs never).
The duration of use (Table III), age at first use or age at
latest use were not associated with melanoma development.
No association between the timing of taking oral contra-
ceptives in relation to first child (number of years before or
after) and risk of melanoma was found. We found ORs for
oral contraceptive use to be virtually the same when the study
was restricted to those most likely to have used them-women
aged 20-60 years.
A total of 13% of cases and 14% of controls had ever
used menopausal replacement therapy, and the adjusted OR
for developing malignant melanoma after ever having used
menopausal replacement therapy was 1.0 (95% CI 0.5 - 1.8).
As for oral contraceptives, no associations were found
between melanoma and duration of menopausal replacement
therapy use, age at first use or age at latest use.
When reproductive and hormonal factors were considered
in site-specific analyses (melanoma of the trunk compared vs
the extremity or head and neck) the results did not differ
from the overall results.
Among other factors studied, blood transfusion was not
significantly associated with subsequent melanoma develop-
ment (OR= 1.2, 95% CI 0.8-1.9 for any prior blood
transfusion vs none).
Original material
When all the analyses were performed on all cases with a first
histopathological diagnosis of malignant melanoma (accord-
ing to the Tumour Registry) who had answered the
questionnaire and also had at least one matched control,
the ORs did not essentially differ from those reported above.
However, among prescribed drugs use of beta-blockers were,
in the same manner as described above for use of
tranquillisers, not significantly associated with melanoma
development when adjustments for constitutional factors
were performed (adjusted OR = 1.5, 95% CI 0.9-2.3 for
use of at least one month continuously vs no use). Analyses
on endogenous and exogenous hormonal exposure were
performed on 205 female cases and 327 female controls.
Discussion
The aim of this report was to present data on melanoma risk
according to use of commonly prescribed drugs, alcohol
intake, smoking habits and reproductive and hormonal
factors. Analyses were carried out both on histopathologi-
cally reviewed (re-examined material) and non-re-examined
material (original material) to allow a comparison of our
results with results from studies with histopathologically
reviewed sections and other studies based on registry
material. Both types of analyses gave virtually the same
odds ratios.
Interestingly, use of beta-blockers and benzodiazepines
respectively showed elevated ORs for melanoma develop-
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ment. However, our data on prescribed drugs were based on
ever use, before diagnosis/interview, for more than a month
continuously, and no information was available regarding
dosage, age at first use, time since last use and total lifetime
exposure. Thus, non-differential misclassification (i.e. mea-
surement error that is independent of disease status) of drug
exposure may to some degree have been present but the effect
of this error would rather have been to bias our measure of
association toward the null value. We have no reason to
believe that the data on drug use differ between cases and
controls since neither group could have been aware of the
hypothesis. The associations were virtually the same after
adjustments for sunburns but were attenuated and, at least
for benzodiazepines, non-significant when constitutional
factors were also taken into account. Thus, the association
between use of benzodiazepines and risk of melanoma seems
to have been generated by confounding with constitutional
factors. However, there was no apriori reason to suspect that
host factors would confound a relation between use of
prescribed drugs and melanoma. Host factors were consid-
ered confounders, and therefore included in the analyses,
only because they have been identified as independent risk
factors (Westerdahl et al., 1995). It may also be argued that
the analyses should not be adjusted for constitutional factors
as there is a possibility that they may be part of the causal
pathway and thus not true confounders.
Use of hydralazines also showed an association with
melanoma.
The reason(s) for our results is(are) unknown. If the
results represent true relations, there may exist biologically
possible explanations, as it is known that a variety of drugs
have affinity for melanin (Larsson, 1993) and that
melanocytes contain bioactivating enzymes (Agarwal et al.,
1991). Furthermore, many commonly prescribed drugs
increase the sensitivity of our skin to sunlight (Hawk, 1990;
Allen, 1993). However, it is also possible that the elevated
ORs may be due to chance because of the multiple testing in
our study. Still another possibility would be that such
associations reflect frequency of contact with medical care,
and thus diagnostic opportunity. However, oral contraceptive
users as well as other prescribed drug users also have contact
with the health care system on a regular basis but we found
no elevated ORs for melanoma among them. Whether our
results on beta-blockers and benzodiazepines may be due to
chance, generated by confounding or represent true findings
need to be further investigated. In the epidemiological
literature almost no attention has been paid to a possible
association between pharmaceutical drugs and melanoma. So
far, only a few studies have briefly mentioned negative results
without displaying data (Beral et al., 1988; Adam et al., 1981;
Green et al., 1986).
It has been hypothesised that melanoma development
may be promoted by alcohol-induced pituitary secretion of
melanocyte-stimulating hormone (Williams, 1976). Several
studies have therefore investigated the association between
alcohol and melanoma (Williams and Horm, 1977; Green et
al., 1986; Holman et al., 1986; 0sterlind et al., 1988a;
Stryker et al., 1990; Adami et al., 1992; Bain et al., 1993;
Kirkpatrick et al., 1994). A positive relation has been
reported in four studies (William and Horm, 1977; Holman
et al., 1986; Stryker et al., 1990; Bain et al., 1993). In a
case -control study based on the Third National Cancer
Survey, a non-significant positive association between
alcohol and melanoma was demonstrated (William and
Horm, 1977). Stryker et al. (1990) found an alcohol
consumption over 10 g per day to be a risk factor for
melanoma. Their results for total alcohol intake did not
differ between superficial spreading melanoma and other
types. Similarly, in a study from Western Australia elevated
ORs were found for alcohol consumption in relation to
melanoma, albeit significant only for the small group with
unclassifiable melanoma (Holman et al., 1986). Moreover,
Bain et al. (1993) reported that women drinking 20 g or
more alcohol per day had 2.5 times the risk of melanoma as
non-drinkers. However, the elevated OR was not statisticallyDrugs, alcohol, smoking, hormones and melanoma
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significant. Except for the latter study none of these positive
studies have adequately considered sun exposure as a
possible confounder. In contrast, a study by 0sterlind et
al. (1988a) demonstrated a significant trend for decreasing
melanoma risk with increasing alcohol intake. In our study
we found no elevated ORs for developing malignant
melanoma according to either total alcohol intake or
alcohol intake categorised as light beer, beer, wine and
distilled liquor. Furthermore, no variations by sex or age
were demonstrated. In the present study we did control for
sun exposure; however, the results were unchanged. Our
findings are in accordance with the results from several other
studies (Green et al., 1986; Adami et al., 1992; Kirkpatrick
et al., 1994). Therefore, when considering all available data
together it seems unlikely that alcohol intake is an
independent risk factor for melanoma.
In accordance with previous findings (Williams and Horm,
1977; Paffenberger et al., 1978; Green et al., 1986; Holman et
al., 1986; 0sterlind et al., 1988a), smoking did not seem to
significantly influence melanoma risk.
Since it has been oberved that endogenous female
hormones might influence melanoma incidence (Boyle and
Robertson, 1987) and prognosis (Holly, 1986), and that
hyperpigmentation occurs during pregnancy and oral contra-
ceptive use (Sanchez et al., 1981), it has been hypothesised
that there could be an association between sexual hormones
(endogenous and/or exogenous) and melanoma development
in female. Several studies have therefore, in addition to the
results reported on oral contraceptives, to a varying extent
also investigated menstrual and reproductive factors (Holly et
al., 1983; Holman et al., 1984; Gallagher et al., 1985; Green
and Bain, 1985; Osterlind et al., 1988b; Zanetti et al., 1990;
Hannaford et al., 1991; Le et al., 1992). Like Gallagher et al.
(1985) we found support for a decrease in melanoma risk (a
significant trend) for women with greater number of live
births. In an Italian study an inverse association between
number of live births and melanoma was found to be
diminished by adjustment for education, sun exposure and
sun susceptibility (Zanetti et al., 1990). Gallagher et al. (1985)
did not take sun exposure into account in their analyses. Six
other studies have reported on this issue (Holly et al., 1983;
Holman et al., 1984; Green and Bain, 1985; 0sterlind et al.,
1988b; Hannaford et al., 1991; Le et al., 1992), and four of
them have shown a non-significantly decreased risk (Holly et
al., 1983; Holman et al., 1984; Osterlind et al., 1988b;
Hannaford et al., 1991). Holly et al. (1983) demonstrated
delayed childbearing to be related to increased melanoma
risk. This was true only for superficial spreading melanoma
and in the analysis only adjustments for oral contraceptive
use and education were done. In a recent study menarche
before age 14 years was suggested to be associated with
melanoma risk (Le et al., 1992). As have others (Holman et
al., 1984; Gallagher et al., 1985; Green and Bain, 1985;
0sterlind et al., 1988b), we found no evidence of a significant
effect of either age at first birth or age at menarche on
melanoma risk. Our findings and the disparity in results
between the previous studies suggest no large impact of
reproductive and menstrual factors on melanoma risk.
However, further studies are needed to draw definitive
conclusions on the relation between number of live births
and risk of melanoma.
Previous reports of oral contraceptives and malignant
melanoma have predominantly failed to shown any associa-
tion (Bain et al., 1982; Helmrich et al., 1984; Holman et al.,
1984; Gallagher et al., 1985; Green and Bain, 1985; Osterlind
et al., 1988b; Zanetti et al., 1990). In some studies an
increased risk has been observed for long duration of use
(Beral et al., 1977, 1984; Adam et al., 1981; Holly et al., 1983;
Hannaford et al., 1991; Le et al., 1992) or for use that started
many years before diagnosis and lasted several years (Holly
et al., 1983; Beral et al., 1984; Le et al., 1992). However, most
of these estimates were non-siginificant (Beral et al., 1977;
Adam et al., 1981; Hannaford et al., 1991) and some
estimates were not adjusted for sun exposure variables
(Beral et al., 1977; Holly et al., 1983; Hannaford et al.,
1991; Le et al., 1992). In accordance with most studies (Beral
et al., 1977; Adam et al., 1981; Bain et al., 1982; Helmrich et
al., 1984; Holman et al., 1984; Gallagher et al., 1985; Green
and Bain, 1985; 0sterlind et al., 1988b; Zanetti et al., 1990;
Hannaford et al., 1991; Palmer et al., 1992), our data on
duration of oral contraceptive use and time when use took
place, do not suggest a significant association between oral
contraceptives and melanoma. However, hyperpigmentation
during use of oral contraceptives and pregnancy typically
occur in the face, but also around the breast and the
umbilicus. Only a few studies have performed analyses of risk
of site-specific melanoma in relation to oral contraceptive use
(Beral et al., 1977, 1984; Zanetti et al., 1990). In one study,
with heterogeneous data, an excess of lesions of the lower
limbs was reported (Beral et al., 1977). In the present study,
as in two other studies (Beral et al., 1984; Zanetti et al.,
1990), site-specific analyses (trunk vs extremeties or head and
neck) did not show any difference from the overall results.
Unfortunately, few, if any, of the studies (including ours)
have been large enough to allow site-specific analyses to
consider different sites more in detail.
As have others, we found no significant association
between hormonal replacement therapy and melanoma risk
(Beral et al., 1977, 1984; Adam et al., 1981; Holman et al.,
1984; Gallagher et al., 1985; Osterlind et al., 1988b).
To reduce the likelihood of selection bias, it was
ascertained that all cases with a first diagnosis of melanoma
within a defined area had been included and that controls
were randomly selected from the general population of the
same area. Furthermore, without knowing our hypothesis, a
large percentage of cases and controls answered the
comprehensive questionnaire. However, the response rate
was somewhat higher for cases than for controls. It is difficult
to assess fully the potential bias introduced by the differences
in response rate between cases and controls, but there is no a
priori reason to suspect that identified risk factors in this
study are associated with non-participation.
One important methodological issue when performing a
multivariate analysis is the issue of which variables to control
for (see also above - prescribed drugs). Among possible
confounders exposure to sunlight is the most important.
The multivariate models included adjustments for number of
sunburns as this factor was identified as the most important
measure of sun exposure in this case-control study
(Westerdahl et al., 1994a). Analyses adjusted for other
factors regarding sun exposure gave the same results.
However, we cannot exclude that our findings could be due
to uncontrolled confounding by a sun exposure variable and/
or another variable not measured in the questionnaire.
Another major source of bias in case-control studies is
measurement errors. Although the self-administered ques-
tionnaire used in this case-control study has been shown to
provide information with good test-retest reliability
(Westerdahl et al., 1996), the influence of non-differential
misclassification may have been substantial, as stated above
for prescribed drugs, as measures of exposures analysed were
crude. In this context it is important to remember that our
data on constitutional factors also relied on self-assessment.
However, it is widely appreciated that the effect of non-
differential misclassification is to lead to an underestimation
of a true relationship. A particular concern in case-control
studies is recall bias (i.e. if cases report differently than
controls). In the present study identical procedures of data
collection for cases and controls were used, the information
from cases was collected close in time to the diagnosis in
order to avoid the influence that the diagnosis of melanoma
may have on recall, and subjects were unaware of our
hypothesis. Furthermore, reported smoking habits, which are
the object of health concern among the general population,
were similar for cases and controls. We therefore do not
think that misclassification because of reporting errors differs
between cases and controls.
In conclusion, our results suggest that alcohol, smoking,
reproductive or hormonal factors do not increase the risk of
melanoma. However, increasing number of live births may beDrugs, alcohol, smoking, hormones and melanorna
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protective. Some support is lent to the possibility that specific
types of prescribed drugs (beta-blockers. hydralazine and
benzodiazepines) mav be associated wvith melanoma. How-
ever. these findings wvere diminished. at least for benzodia-
zepines. after adjustment for host factors and as they are
unconfirmed. and may be due to chance or to confoundine.
further investigation is needed.
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